[1]
Q. U. A. Nazar, M. Amna, and Z. Asif, “Glucagon like peptide-1 receptor agonist (Ozempic): Revolutionising chronic kidney disease management in diabetes”., J Pak Med Assoc, vol. 76, no. 04, pp. 624–624, Mar. 2026.